ArticleClinical lymphoma, myeloma & leukemia2018
Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics.
Vincent T Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.